EN
HI
Summary
As of 16 Sep, 2026, Zydus Lifesciences stock price is ₹1107.5. During the trading session, the stock has moved between an intraday low of ₹1086.00 and an intraday high of ₹1113.30. Over the last 52 weeks, Zydus Lifesciences has traded between ₹835.50 and ₹1205.00.
The stock has recorded a trading volume of 6,89,380 shares,. Its Average Traded Price (ATP) is ₹1102.63, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 2 @ ₹1107.50.
Zydus Lifesciences has an upper circuit limit of ₹1208.90 and a lower circuit limit of ₹989.10. The total value traded stands at ₹76.01 CR, and the delivery percentage for the day is 56.09%.
The stock is currently traded with a market lot size of 1. Zydus Lifesciences also offers a dividend yield of 0.09%.
Zydus Lifesciences Share Price Chart
Zydus Lifesciences Share Key Metrics
Volume
6.89 L
Market Cap
111440.41 CR
LTQ@LTP
2@1107.50
ATP
1102.63
Var Margin
13.23 %
Circuit Range
989.1-1208.9
Delivery %
56.09 %
Value
76.01 CR
ASM/GSM
No
Market Lot
1
Zydus Lifesciences Fundamentals
P/E Ratio
24.29
P/B Ratio
4.07
Div. Yield
0.09
Sector P/E
40.7
Sector P/B
3.52
Sec. Div. Yield
0.51
Zydus Lifesciences Resistance and Support
Pivot 1107.5
Resistance
First Resistance
1116
Second Resistance
1133
Third Resistance
1141.5
Support
First Support
1090.5
Second Support
1082
Third Support
1065
Zydus Lifesciences Futures & Options
Zydus Lifesciences Option Chain
View Price, OI, Greeks & More...
29SEP26
1114.30
11.20 (1.02%)
27OCT26
1114.00
5.70 (0.51%)
23NOV26
1120.50
5.30 (0.48%)
ZYDUSLIFE|29SEP26 CE 1100.00
28.35
4.45 (18.62%)
ZYDUSLIFE|29SEP26 PE 1110.00
18.95
-6.2 (-24.65%)
Zydus Lifesciences Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Wed Sep 16 2026 | 1093.7 | 1107.5 | 0.77% | 1113.3 | 1086 |
| Tue Sep 15 2026 | 1120.09 | 1099 | -1.80% | 1124.5 | 1099 |
| Fri Sep 11 2026 | 1114 | 1119.09 | 0.12% | 1135.5 | 1104.59 |
Zydus Lifesciences Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-11 | Quarterly Results |
| 2026-05-19 | Audited Results |
| 2026-02-09 | Quarterly Results |
| 2025-11-06 | Quarterly Results & Fund raising |
| 2025-08-12 | Quarterly Results |
| 2025-05-20 | Audited Results & Final Dividend |
| 2025-02-05 | Quarterly Results |
| 2024-11-12 | Quarterly Results |
Zydus Lifesciences News
Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Credit Rating
CRISIL Ratings reaffirmed Zydus Life Science's long-term rating at 'AAA/Stable' for various bank facilities and non-convertible debentures. Short-term ratings, including commercial papers, were reaffirmed at 'A1+'. This indicates a very strong degree of safety for timely payment.
Sep 11 2026 14:35:31
Zydus Lifesciences Ltd - 532321 - Incorporation Of A Wholly Owned Subsidiary In Gift City, Gandhinagar, Gujarat
Zydus Lifesciences Limited has incorporated a new wholly-owned subsidiary, Zydus Global Treasury Centre IFSC Limited, in Gift City, Gandhinagar. The new entity will undertake global and regional corporate treasury activities.
Aug 26 2026 11:15:50
Read More
Zydus Lifesciences Management
| Name | Position |
|---|---|
| Dhaval N Soni | Company Secretary & Compliance Officer |
| Pankaj R Patel | Chairman |
Zydus Lifesciences Similar Stocks
Sun Pharmaceutical Industries Ltd.
1853.50
18.50 (1.01%)
Divi's Laboratories Ltd.
9158.00
-40.00 (0.43%)
Torrent Pharmaceuticals Ltd.
4812.50
-37.50 (0.77%)
Apollo Hospitals Enterprise Ltd.
8696.50
-17.50 (0.20%)
Lenskart Solutions Ltd.
675.85
-9.55 (1.39%)
Cipla Ltd.
1358.00
7.00 (0.52%)
Laurus Labs Ltd.
1905.50
-21.40 (1.11%)
Max Healthcare Institute Ltd.
1025.00
-5.00 (0.49%)
Dr. Reddy's Laboratories Ltd.
1140.00
-5.00 (0.44%)
Aurobindo Pharma Ltd.
1643.00
-17.00 (1.02%)
Zydus Lifesciences FAQs
The Buying Price of Zydus Lifesciences share is 1107.5 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Zydus Lifesciences stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Zydus Lifesciences, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Zydus Lifesciences shares is 24.29. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Zydus Lifesciences shares is 4.07. Useful to assess the stock's value relative to its book value.
To assess Zydus Lifesciences’s valuation compare Sector P/E, P/B which are 40.7 & 3.52 with sector averages, along with growth rates and financial metrics.
The Market Cap of Zydus Lifesciences is 111440.41 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Zydus Lifesciences share price is 1205.00 & 835.50. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Zydus Lifesciences belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in ZYDUSLIFE
